Tennessee is a leading state in the incidence of opioid addiction and opioid overdose. This is most likely a direct result of Tennessee being ranked one of the country’s leading states for the prescription of opioids as well as benzodiazepines like xanax and klonopin.
The CDC (Centers for Disease Control and Prevention) report that 46 people die every day in the United States from overdose on prescription painkillers. They also have documented that 259 million prescriptions for opioids were written in 2012 alone by U.S. healthcare providers. This stunning proliferation of opioids has sparked national concerns about opioid addiction and why painkillers have been made so readily available.
In Tennessee, Behavioral Health Group (BHG) have responded to the crisis by providing opioid treatment in a variety of Tennessee cities. They currently operate three clinics in Memphis: Memphis North, Memphis Mid-Town, and Memphis South Treatment Centers under the BHG banner.
BHG also have clinics in Knoxville, Nashville, Jackson, Paris, Columbia, and Dyersburg. The company’s locations all provide suboxone (buprenorphine) in addition to methadone to aid opioid addicted individuals in their effort to cope with powerful opiate withdrawal symptoms. BHG provide various forms of supportive counseling to their patients in conjunction with their medication-assisted treatment model.
While local and federal governments work to address the rise in opioid addiction, it remains very important that addicted individuals seek and find effective treatment as soon as possible. Those interested in participating in opioid treatment often have questions about the process of enrolling in treatment and what it is actually like receiving methadone or suboxone in a clinic setting. Methadone.US offers helpful information on our site for prospective patients that provides an overview of the opioid treatment enrollment process.
Follow
